PC
IBB icon

PointState Capital’s iShares Biotechnology ETF IBB Stock Holding History

PointState Capital’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-100,000
Closed -$15.1M – 143
2020
Q4 		$15.1M Buy
+100,000
New +$14.3M 0.28% 67

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

PointState Capital's IBB Position: Q1 2018 in Review

PointState Capital sold out of iShares Biotechnology ETF (IBB) in Q1 2018, closing a stake of 14,700 shares — an estimated $1.57M sold.

PointState Capital first reported a position in IBB in Q4 2014 and held it in 6 quarters. The position peaked at $15.2M in Q4 2014. 607 funds tracked by Wall St. Rank hold IBB as of Q1 2018.

  • PointState Capital reported no remaining iShares Biotechnology ETF position as of Q1 2018 after selling out during the quarter.
  • PointState Capital sold 14,700 iShares Biotechnology ETF shares in Q1 2018, an estimated $1.57M.
  • PointState Capital first reported a position in iShares Biotechnology ETF in Q4 2014 and held it in 6 quarters.
  • PointState Capital's iShares Biotechnology ETF position peaked at $15.2M in Q4 2014.
  • 607 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2018.

Based on PointState Capital's 13F filing for Q1 2018, filed 15 May 2018.